Table 1 Demographic and clinical characteristics, quality of sleep, fatigue, and daytime sleepiness in 110 RA female patients

Age, years (mean ± SD)

51.2 ± 8.1

52.3 ± 13.3

48.6 ± 12.15

0.054^b

Disease duration, years (mean ± SD)

8.1 ± 7.8

8.9 ± 8.5

6.4 ± 5.7

0.147^b

DAS28 score^a (mean ± SD)

3.89 ± 1.45

3.7 ± 1.4

4.36 ± 1.53

0.047^b

Moderate / high activity disease (DAS28 > 3,2), n (%)^a

50(59.5)

31(53.4)

19(73.1)

0.100^c

PSQI global score (mean ± SD)

8.21 ± 3.93

7.33 ± 3.55

10.09 ± 4.1

0.001^b

Poor sleep, n (%)

78(70.9)

48(64)

30(85.7)

0.024^c

FSS (mean ± SD)

3.77 ± 1.93

3.34 ± 1.8

4.69 ± 1.89

0.001^b

Fatigue, n (%)

47(42.7)

26(34.7)

21(60)

0.014^c

ESS (mean ± SD)

8.73 ± 5.41

8.39 ± 5.04

9.46 ± 6.15

0.450

EDS, n (%)

43(39.1)

28(37.3)

15(42.9)

0.676^c

BDI-II (mean ± SD)

10.84 ± 9.11

5.55 ± 3.94

21.89 ± 6.65

< 0.01^b